يعرض 1 - 10 نتائج من 37 نتيجة بحث عن '"Abollo-Jimenez, Fernando"', وقت الاستعلام: 1.44s تنقيح النتائج
  1. 1
  2. 2
    دورية أكاديمية

    المصدر: Ruiz-Babot, Gerard; Eceiza, Ariane; Abollo-Jiménez, Fernando; Malyukov, Maria; Carlone, Diana L; Borges, Kleiton; Da Costa, Alexandra Rodrigues; Qarin, Shamma; Matsumoto, Takuya; Morizane, Ryuji; Skarnes, William C; Ludwig, Barbara; Chapple, Paul J; Guasti, Leonardo; Storr, Helen L; Bornstein, Stefan R; Breault, David T (2023). Generation of glucocorticoid-producing cells derived from human pluripotent stem cells. Cell Reports Methods, 3(11):100627.

    وصف الملف: application/pdf

    العلاقة: https://www.zora.uzh.ch/id/eprint/255646/1/ZORA255646.pdfTest; info:pmid/37924815; urn:issn:2667-2375

  3. 3
    دورية أكاديمية
  4. 4
    رسالة جامعية
  5. 5
    دورية أكاديمية

    وصف الملف: text

    العلاقة: https://eprints.soton.ac.uk/448314/1/Angelica_Gualtieri_et_al_BRAF_mutations_disrupt_the_hypothalamo_pituitary_axis_leading_to_hypopituitarism_in_mouse_and_humans_Nature_Communications_20201.pdfTest; Gualtieri, Angelica, Kyprianou, Nikolina, Gregory, Louise C, Vignola, Maria Lillina, Nicholson, James G, Tan, Rachael, Inoue, Shin-Ichi, Scagliotti, Valeria, Casado, Pedro, Blackburn, James, Abollo-Jimenez, Fernando, Marinelli, Eugenia, Besser, Rachael, Hogler, Wolfgang, Temple, Karen, Davies, Justin, Gagunashvili, Andrey, Robinson, Iain C.A.F., Camper, Sally A, Davis, Shannon W, Cutillas, Pedro, Gevers, Evelien F, Aoki, Yoko, Dattani, Mehul T. and Gaston-Massuet, Carles (2021) Activating mutations in BRAF disrupt the hypothalamo-pituitary axis leading to hypopituitarism in mice and humans. Nature Communications, 12 (1), [2028]. (doi:10.1038/s41467-021-21712-4 ).

  6. 6
    دورية أكاديمية

    المساهمون: Alors-Perez,E, Blázquez-Encinas,R, Viyuela-García,C, Pedraza-Arevalo,S, Herrero-Aguayo,V, Jiménez-Vacas,JM, Sánchez-Frías,ME, Cano,MT, Abollo-Jiménez,F, Marín-Sanz,JA, Sánchez-Hidalgo,JM, Ventura,S, Gahete,MD, Arjona-Sánchez,A, Ibáñez-Costa,A, Luque,RM, Castaño,JP Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Córdoba, Spain. Alors-Perez,E, Castaño,JP Department of Cell Biology, Physiology, and Immunology, University of Cordoba, Córdoba, Spain. Alors-Perez,E, Castaño,JP Reina Sofia University Hospital, Córdoba, Spain. Alors-Perez,E, Castaño,JP CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Edificio IMIBIC, Córdoba, Spain. Alcalá,S, Martin-Hijano,L, Sainz,B Department of Biochemistry, Universidad Autónoma de Madrid (UAM) and Department of Cancer Biology, Instituto de Investigaciones Biomédicas Alberto Sols (IIBM), CSIC-UAM, Madrid, Spain. Alcalá,S, Martin-Hijano,L Department of Cancer Biology, Chronic Diseases and Cancer Area 3-Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain. Viyuela-García,C, Arjona-Sánchez,A Surgery Service, Reina Sofia University Hospital, Córdoba, Spain. Mafficini,A, Lawlor,RT, Luchini,C, Scarpa,A ARC-Net Research Centre, University and Hospital Trust of Verona, Verona, Italy. Sánchez-Frías,ME Pathology Service, Reina Sofia University Hospital, Córdoba, Spain. Cano,MT Medical Oncology Service, Reina Sofia University Hospital, Córdoba, Spain. Abollo-Jiménez,F, Ventura,S Department of Computer Sciences, University of Cordoba, Córdoba, Spain. Cabezas-Sainz, P, Sánchez,L Department of Zoology, Genetics and Physical Anthropology, University of Santiago de Compostela, Lugo, Spain. Luchini,C, Scarpa,A Department of Diagnostics and Public Health, Section of Pathology, University and Hospital Trust of Verona, Verona, Italy. Sainz,B Centro de Investigación Biomédica en Red, Área Cáncer, CIBERONC, ISCIII, Madrid, Spain, This work has been supported by Spanish Ministry of Economy MINECO, BFU2016–80360-R (to JPC) and Ministry of Science and Innovation MICINN, PID2019-105201RB-I00 (to JPC), PID2019-105564RB-I00 (to RML) . Instituto de Salud Carlos III, co-funded by European Union (ERDF/ESF, “Investing in your future”) FIS Grants PI17/02287 and PI20/01301 (to MDG), PI18/00757 (to BS,Jr), DTS Grant DTS20/00050 (to RML)), Postdoctoral Grant Sara Borrell CD19/00255 (to AIC), Predoctoral contract FI17/00282 (to EAP) . Coordinated grant (GC16173694BARB) from the Fundación Asociación Española Contra el Cáncer (AECC) (to BS,Jr). Spanish Ministry of Universities Predoctoral contracts FPU14/04290 (to SPA), FPU16/06190 (to VHA), FPU18/02275 (to RBE) . Boehringer Ingelheim Fonds travel grant (EAP). Junta de Andalucía (BIO-0139). GETNE2016 and GETNE2019 Research grants (to JPC), and CIBERobn. Associazione Italiana Ricerca Cancro (AIRC 5 × 1000 n. 12182), Fondazione Italiana Malattie Pancreas – Ministero Salute FIMPCUP_J38D19000690001, Fondazione Cariverona: Oncology Biobank Project “Antonio Schiavi” (prot. 203885/2017).

    وصف الملف: application/pdf; application/vnd.openxmlformats-officedocument.wordprocessingml.document

    العلاقة: https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02153-9Test; Alors-Perez E, Blázquez-Encinas R, Alcalá S, Viyuela-García C, Pedraza-Arevalo S, Herrero-Aguayo V, et al. Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug. J Exp Clin Cancer Res. 2021 Dec 2;40(1):382; http://hdl.handle.net/10668/4513Test; PMC8638119

  7. 7
    دورية أكاديمية
  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية

    المساهمون: Ministerio de Ciencia e Innovación (España), Junta de Castilla y León, Ministerio de Educación y Ciencia (España), Fundación Sandra Ibarra - Solidaridad Frente al Cáncer, European Commission, Obra Social Kutxa

  10. 10
    دورية أكاديمية